Lupus kliinilised uuringud osariigis Tennessee
13 uuringut haiguse Lupus jaoks otsivad osalejaid osariigis Tennessee.
Linnad osariigis Tennessee
Ametlik uuringutekst (inglise keeles)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50001, Jackson
- Sl0044 50693, Murfreesboro
VärbamineFaas 3
Vanused 16 ja vanemad · Kõik sood · Uuendatud 2. okt 2026 · NCT06617325A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- West Tennessee Research Institute, Jackson
- Shelby Research LLC, Memphis
VärbamineFaas 2
Vanused 18–74 · Kõik sood · Uuendatud 1. okt 2026 · NCT07409181Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- West Tennessee Research Institute, Jackson
- Shelby Research LLC, Memphis
VärbamineFaas 3
Vanused 12–100 · Kõik sood · Uuendatud 1. okt 2026 · NCT06133972A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, Memphis
- Research Site, Memphis
VärbamineFaas 3
Vanused 18–70 · Kõik sood · Uuendatud 25. sept 2026 · NCT07430306A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- West Tennessee Research Institute, Jackson
VärbamineFaas 3
Vanused 18–75 · Kõik sood · Uuendatud 25. sept 2026 · NCT07438496A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
- West Tennessee Research Institute - Jackson /ID# 284561, Jackson
VärbamineFaas 1
Vanused 18–75 · Kõik sood · Uuendatud 25. sept 2026 · NCT07607964A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Murfreesboro Medical Clinic, Murfreesboro
VärbamineVaatlusuuring
Vanused 16 ja vanemad · Kõik sood · Uuendatud 3. sept 2026 · NCT07175285A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
- Private Practice - Dr. Ramesh C. Gupta /ID# 275826, Memphis
VärbamineFaas 1
Vanused 18–75 · Kõik sood · Uuendatud 10. aug 2026 · NCT06977724A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
- Investigative Site, Memphis
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 27. juuli 2026 · NCT07260877A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
- Regional One Health, Memphis
VärbamineFaas 1
Vanused 18–70 · Kõik sood · Uuendatud 5. juuni 2026 · NCT066133602-HOBA in Systemic Lupus Erythematosus
- Vanderbilt University Medical Center, Nashville
VärbamineFaas 2
Vanused 18 ja vanemad · Naised · Uuendatud 22. mai 2026 · NCT07225543A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Regional One Health, Memphis
VärbamineFaas 1
Vanused 12–70 · Kõik sood · Uuendatud 22. mai 2026 · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- Vanderbilt University Medical Center, Nashville
VärbamineVaatlusuuring
Vanused 18–110 · Kõik sood · Uuendatud 15. apr 2026 · NCT05934149Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.